Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study

• Main Authors: Christabel Khaemba (Author), Abbie Barry (Author), Wyckliff P. Omondi (Author), Kefa Bota (Author), Sultani Matendechero (Author), Cecilia Wandera (Author), Fred Siyoi (Author), Elvis Kirui (Author), Margaret Oluka (Author), Pamela Nambwa (Author), Parthasarathi Gurumurthy (Author), Sammy M. Njenga (Author), Anastacia Guantai (Author), Eleni Aklillu (Author)
• Format: Book
• Published: MDPI AG, 2021-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Preventive chemotherapy with diethylcarbamazine citrate (DEC) and albendazole (ALB) is the core intervention strategy to eliminate lymphatic filariasis (LF). We conducted a large-scale prospective active safety surveillance study to identify the incidence, type, severity, and risk factors for advers...